Jackson, V. Margaret

A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor

Griffith, D. A., Edmonds, D. J., Fortin, J.-P., Kalgutkar, A. S., Kuzmiski, J. B., Loria, P. M., Saxena, A. R., Bagley, S. W., Buckeridge, C., Curto, J. M., et al. (2022) · Journal of Medicinal Chemistry

Diabetes Treatment and ManagementReceptor Mechanisms and Signaling

Cited by 192

Latest approaches for the treatment of obesity

Jackson, V. M., Breen, D. M., Fortin, J.-P., Liou, A., Kuzmiski, J. B., Loomis, A. K., Rives, M.-L., Shah, B., & Carpino, P. A. (2015) · Expert Opinion on Drug Discovery

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 132

Augmented capacity for peripheral serotonin release in human obesity

Young, R. L., Lumsden, A. L., Martin, A. M., Schober, G., Pezos, N., Thazhath, S. S., Isaacs, N. J., Cvijanovic, N., Sun, E. W. L., Wu, T., et al. (2018) · International Journal of Obesity

Regulation of Appetite and ObesityGastrointestinal motility and disorders

Cited by 87

Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate

Bhattacharya, S. K., Andrews, K., Beveridge, R., Cameron, K. O., Chen, C., Dunn, M., Fernando, D., Gao, H., Hepworth, D., Jackson, V. M., et al. (2014) · ACS Medicinal Chemistry Letters

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 73

Oxytocin‐induced contractions within rat and rabbit ejaculatory tissues are mediated by vasopressin V1Areceptors and not oxytocin receptors

Gupta, J., Russell, R. J., Wayman, C. P., Hurley, D., & Jackson, V. M. (2008) · British Journal of Pharmacology

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 66